Cost-effectiveness analysis of pancreatin minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis

References

• Lankisch PG, Lembcke B, Wemken G, et al. Functional reserve capacity of the exocrine pancreas. Digestion 1986;35:175-81
   PubMed Web of Science ®Google Scholar
• Dimagno EP, Go VL, Summerskill WH. Relations between pancreatic enzyme ouputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 1973;288:813-5
   PubMed Web of Science ®Google Scholar
• Keller J, Layer P. Pancreatic Enzyme Supplementation Therapy. Curr Treat Options Gastroenterol 2003;6:369-74
   PubMedGoogle Scholar
• Wehler M, Nichterlein R, Fischer B, et al. Factors associated with health-related quality of life in chronic pancreatitis. Am J Gastroenterol 2004;99:138-46
   PubMed Web of Science ®Google Scholar
• Mokrowiecka A, Pinkowski D, Malecka-Panas E, et al. Clinical, emotional and social factors associated with Quality of Life in Chronic Pancreatitis. Pancreatology 2010;10:39-46
   PubMedGoogle Scholar
• Pezzilli R, Morselli Labate A, et al. Quality of life in patients with chronic pancreatitis. Digest Liver Dis 2005;37:181-9
   Google Scholar
• Clinical expert interviews: Małecka-Panas E, gastroenterology, Łodz (Poland); Imrie C, abdominal surgery and endoscopic practice, Glasgow (Scotland, UK); Frulloni L, gastroenterology and digestive endoscopy, Verona (Italy); Löhr M, gastroenterology, Stockholm (Sweden). Hoofddorp, The Netherlands: Quintiles Consulting; 2011
   Google Scholar
• Mokrowiecka A, Pińkowski D, Małecka-Panas E. Assessment of quality of life in patients with chronic pancreatitis. Med Sci Monit 2011;17:583-8
   Web of Science ®Google Scholar
• Weijers H, Drion E, van der Kamer J. Analysis and interpretation of the fat-absorption coefficient. Acta Paediatr 1960;49:615-25
   Google Scholar
• Toouli J, Biankin A, Oliver M, et al. Management of pancreatic exocrine insufficiency: Australasian Pancreatic Club Recommendations. Med J Aust 2010;193:461-7
   PubMed Web of Science ®Google Scholar
• Hammer H, Schöfl R, Hammer J. Chronische Pankreatitis: Empfehlungen zur Diagnostik und Therapie. Teil II: Behandlung der chronischen Pankreatitis und der Pankreasinsuffizienz: Diät und Medikamente. J Gastroenterol Hepatol Erkr 2006;4:7-11 [German]
   Google Scholar
• Żuk K, Czkwianianc E, Degowska M, et al. Guidelines for diagnosis and treatment of chronic pancreatitis. Recommendations of the Working Group of the Polish National Consultant in Gastroenterology and the Polish Pancreatic Club. Przegląd Gastroenterologiczny 2011;6:339-52 [Polish]
   Google Scholar
• Sikkens EC, Cahen DL, Kuipers EJ, et al. Pancreatic enzyme replacement therapy in chronic pancreatitis. Best Pract Res Clin Gastroenterol 2010;24:337-47
   PubMed Web of Science ®Google Scholar
• Jupp J, Fine D, Johnson C. The epidemiology and socioeconomic impact of chronic pancreatitis. Best Pract Res Clin Gastroenterol 2010;24:219-31
   PubMed Web of Science ®Google Scholar
• Lankisch PG, Assmus C, Maisonneuve P, et al. Epidemiology of pancreatic diseases in Luneburg County. A study in a defined German population. Pancreatology 2002;2:469-77
   PubMed Web of Science ®Google Scholar
• Levy P, Barthet M, Mollard B, et al. Estimation of the prevalence and incidence of chronic pancreatitis and its complications. Gastroenterol Clin Biol 2006;30:838-44
   PubMedGoogle Scholar
• Tinto A, Lloyd D, Kang J, et al. Acute and chronic pancreatitis – diseases on the rise; a study of hospital admission in England 1989/90 – 1999/2000. Aliment Pharmacol Ther 2002;16:2097-105
   PubMedGoogle Scholar
• Rothenbacher D, Low M, Hardt P, et al. Prevalence and determinants of exocrine pancreatic insufficiency among older adults: results of a population-based study. Scand J Gastroenterol 2005;40:697-704
   PubMed Web of Science ®Google Scholar
• Dumasy V. Fat malabsorption screening in chronic pancreatitis. Am J Gastroenterol 2004;99:1350-4
   PubMed Web of Science ®Google Scholar
• AOTM: Rekomendacja Rady Konsultacyjnej AOTM nr 11/03/2008 z dnia 17 marca 2008 r. http://www.aotm.gov.pl/index.php?id=112. Accessed May 4, 2012
   Google Scholar
• Ammann RW, Heitz PU, Kloppel G. Course of alcoholic chronic pancreatitis: a prospective clinicomorphological long-term study. Gastroenterology 1996;111:224-31
   PubMed Web of Science ®Google Scholar
• Ammann RW, Muellhaupt B, Meyenberger C, et al. Alcoholic nonprogressive chronic pancreatitis: prospective long-term study of a large cohort with alcoholic acute pancreatitis (1976–1992). Pancreas 1994;9:365-73
   PubMedGoogle Scholar
• Cavallini G, Frulloni L, Pederzoli P, et al. Long-term follow-up of patients with chronic pancreatitis in Italy. Scand J Gastroenterol 1998;33:880-9
   PubMed Web of Science ®Google Scholar
• Dani R, Penna FJ, Nogueira CE. Etiology of chronic calcifying pancreatitis in Brazil: a report of 329 consecutive cases. Int J Pancreatol 1986;1:399-406
   PubMedGoogle Scholar
• Lankisch PG, Lohr-Happe A, Otto J, et al. Natural course in chronic pancreatitis. Pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease. Digestion 1993;54:148-55
   PubMed Web of Science ®Google Scholar
• Layer P, Yamamoto H, Kalthoff L, et al. The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology 1994;107:1481-7
   PubMed Web of Science ®Google Scholar
• Marks I, Bank S, Louw J. Chronic pancreatitis in the Western Cape. Digestion 1973;9:447-53
   PubMed Web of Science ®Google Scholar
• Robles-Diaz G, Vargas F, Uscanga L, et al. Chronic pancreatitis in Mexico City. Pancreas 1990;5:479-83
   PubMedGoogle Scholar
• Yadav D. Recent advances in the epidemiology of alcoholic pancreatitis. Curr Gastroenterol Rep 2011;13:157-65
   PubMedGoogle Scholar
• Yadav D, Hawes R, Brand R, et al. Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Arch Intern Med 2009;169:1035-45
   PubMedGoogle Scholar
• Frulloni L, Gabbrielli A, Pezzilli R, et al. Chronic pancreatitis: report from a multicenter Italian survey (PanCroInfAISP) on 893 patients. Dig Liver Dis 2009;41:311-7
   PubMedGoogle Scholar
• Balakrishnan V, Unnikrishnan A, Thomas V, et al. Chronic pancreatitis. A prospective nationwide study of 1,086 subjects from India. JOP 2008;9:588-92
   PubMedGoogle Scholar
• Wang LW, Li ZS, Li SD, et al. Prevalence and clinical features of chronic pancreatitis in China: a retrospective multicenter analysis over 10 years. Pancreas 2009;38:248-54
   PubMed Web of Science ®Google Scholar
• Andriulli A, Botteri E, Almasio PL, et al. Smoking as a cofactor for causation of chronic pancreatitis: a meta-analysis. Pancreas 2010;39(8):1205-10
   PubMedGoogle Scholar
• Gullo L, Barbara L, Labo G. Effect of cessation of alcohol use on the course of pancreatic dysfunction in alcoholic pancreatitis. Gastroenterology 1988;95:1063-8
   PubMed Web of Science ®Google Scholar
• Ockenga J. Importance of nutritional management in diseases with exocrine pancreatic insufficiency. IHPBA 2009;11:11-15
   Google Scholar
• Rady Konsultacyjnej AOTM: Uchwała nr 11/03/2008 z dnia 17 marca 2008 r. sprawie finansowania ze środków publicznych pankreatyny (Kreon 25000®) w leczeniu przewlekłego zapalenia trzustki. http://www.aotm.gov.pl/index.php?id=112. Accessed February 10, 2012
   Google Scholar
• FDA-approved Medication Guide CREON (pancrelipase) Delayed-Release Capsules (for patients). North Chicago, USA: Abbott Laboratories, 2001. http://www.creon.com/Default.htm. Accessed March 2, 2012
   Google Scholar
• O’Keefe SJ, Cariem AK, Levy MJ. The exacerbation of pancreatic endocrine dysfunction by potent pancreatic exocrine supplements in patients with chronic pancreatitis. Clin Gastroenterol 2001;32:319-23
   Google Scholar
• Safdi M, Bekal PK, Martin S, et al. The effects of oral pancreatic enzymes (CREON® 10 capsule) on steatorrhea: a multicenter, placebo controlled, parallel group trial in subjects with chronic pancreatitis. Pancreas 2006;33:156-62
   PubMed Web of Science ®Google Scholar
• Halm U, Loser C, Lohr M, et al. A double-blind, randomized, multicentre, crossover study to prove equivalence of Creon® minimicrospheres versus microspheres in exocrine pancreatic insufficiency. Aliment Pharmacol Ther 1999;13:951-7
   PubMedGoogle Scholar
• Whitcomb DC, Malecka-Panas E, Lehman GA, et al. Efficacy and safety of Creon® delayed-release capsules (Creon®) in patients with pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery. Am J Gastroenterol 2009;104(3 Suppl):S60-S96
   Google Scholar
• Thorat N, Reddy S, Bhatia A, et al. Randomised clinical trial: the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis - a double-blind, placebo-controlled study. Aliment Pharmacol Ther 2012;36:426-36
   PubMedGoogle Scholar
• Lowenfels AB, Maisonneuve P, Cavallini G, et al. Prognosis of chronic pancreatitis: an international multicenter study. International Pancreatitis Study Group. Am J Gastroenterol 1994;89:1467-71
   PubMed Web of Science ®Google Scholar
• Pedrazzoli S, Pasquali C, Guzzinati S, et al. Survival rates and cause of death in 174 patients with chronic pancreatitis. J Gastrointest Surg 2008;12:1930-7
   PubMedGoogle Scholar
• Frulloni L, Falconi M, Gabbrielli A, et al. Italian consensus guidelines for chronic pancreatitis. Dig Liver Dis 2010;42:381-406
   Google Scholar
• Imrie C, Connett G, Hall I, et al. Review article: enzyme supplementation in cystic fibrosis, chronic pancreatitis, pancreatic and periampullary cancer. Aliment Pharmacol Ther 2010;32:1-25
   PubMedGoogle Scholar
• Domíngues-Muñoz E. Pancreatic exocrine insufficiency: diagnosis and treatment. J Gastroentol Hepatol 2011;26:12-16
   Google Scholar
• Poulose K, Holzman D, Speroff T. Optimizing choledocholithiasis management: a cost-effectiveness analysis. Arch Surg 2007;142:43-8
   PubMedGoogle Scholar
• Czarnecki J. Wykaz Leków Refundowanych Numer I/2011. Piotrków Trybunalski: Wydawnictwo JWC 10; 2011
   Google Scholar
• Guidelines for Conducting Health Technology Assessment (HTA). Version 2.1. Warsaw, A 2009. http://aotm.gov.p. Accessed April 22, 2011
   Google Scholar
• Polish drug reimbursement ACT of 12 May 2011. The reimbursement of medicinal products, special purpose dietary supplements and medical devices, Article. 19.2.7 Journal of Laws No. 122, item. 696. Warsaw: SEJM; 2011
   Google Scholar
• Komunikat w sprawie obowiązującej wysokości progu kosztu uzyskania dodatkowego roku życia skorygowanego o jakość. AOTM; 2012 (Feb). http://www.aotm.gov.pl/index.php?id=560. Accessed March 6, 2012
   Google Scholar
• Oanda currency exchange; 2012. www.oanda.com. Accessed March 21, 2012
   Google Scholar
• Gąsiorowska A, Małecka-Panas E. Diagnostyka i leczenie przewlekłego zapalenia trzustki. Gastroenterol 2007;1:76-86
   Google Scholar
• IMS Health, IMS MIDAS Quantum MAT June 2012
   Google Scholar
• Komunikate DGL: Narodowy Fundusz Zdrowia, informacja o refundacji lekow finansowanych ze środków publicznych w Polsce. Warsaw: NFZ; 2012. http://www.nfz.gov.pl/new/index.php?katnr=0&dzialnr=2&artnr=5129 Accessed October 17, 2012
   Google Scholar
• Agency for Healthcare Research and Quality: HCUP-Net. National statistics on hospital stays. Agency for Healthcare Research and Quality. Rockville, USA; 2010. http://hcupnet.ahrg.gov./ Accessed September 12, 2012
   Google Scholar